Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-17

Clinical Trial Update: Evaluation of Tricuspid Valve Percutaneous Repair System in the Treatment of Severe Secondary Tricuspid Disorders [NA]

View source ↗

Summary

A clinical trial evaluating a percutaneous tricuspid valve repair system for severe secondary tricuspid regurgitation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rennes University Hospital | Conditions: Tricuspid Regurgitation | NA | Status: COMPLETED